相关实验视频
Updated: Jan 15, 2026

07:28
Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
Published on: July 2, 2018
9.5K
急性心肌梗塞:分子发病,诊断和临床管理
Mengmeng Zhu1, Yiwen Li2, Qian Xu1
1National Clinical Research Center for Cardiovascular Diseases of Traditional Chinese Medicine Xiyuan Hospital of China Academy of Chinese Medical Sciences Beijing China.
MedComm
|October 9, 2025
概括
急性心肌梗塞 (AMI) 研究现在涵盖了整个疾病过程,包括多器官相互作用. 本综述涵盖了分子机制,临床策略以及AMI预防和管理的未来基于精度的框架.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 系统生物学 系统生物学
背景情况:
- 尽管治疗方面取得了进展,急性心肌梗塞 (AMI) 是全球主要的死亡原因.
- 研究已经从局部损伤扩展到整个疾病过程,包括重塑和器官相互作用.
研究的目的:
- 系统地审查AMI和心室重塑的分子机制.
- 在AMI中探索心脏-肠-大脑-脏-肝脏相互作用.
- 总结AMI管理的临床进展和未来方向.
主要方法:
- 关于分子机制的系统文献综述.
- 在诊断标准和管理方面分析临床演变.
- 新兴治疗策略和未来研究的综合.
主要成果:
- 在AMI和重塑中的关键分子路径的划定.
- 在AMI病变发生过程中,探索器官间交叉的研究.
- 对不断发展的诊断工具 (人工智能集成) 和疗法 (细胞/基因) 的概述.
结论:
- 对AMI的全面理解需要考虑系统性影响和器官间的沟通.
- 将机制性见解与跨学科策略相结合,对于基于精度的AMI预防和管理至关重要.
- 未来的研究应该集中在一个整体的,系统的方法来打击AMI.
相关概念视频
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
354
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
354
Acute Coronary Syndrome IV: Interprofessional Care
219
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219
Acute Coronary Syndrome I: Introduction
804
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
804
Myocarditis II: Clinical Features and Diagnostic Tests
265
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
265
Acute Coronary Syndrome III: Diagnostic Studies
213
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
213
Myocarditis III: Medical Management
174
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
174

